The American College of Physicians' High Value Care Task Force and the Centers for Disease Control and Prevention developed this article to present best practice statements for hepatitis B vaccination, screening, and linkage to care.
On October 16, 2014, the fee-for-service (FFS) pharmacy program implemented clinical criteria for Hepatitis C Virus (HCV) drug therapy, as was recommended by the Drug Utilization Review Board (DURB) at the September 18, 2014 meeting. Included in this criteria were the following ...
The NYC Health Department recently released the City Health Information (CHI): Diagnosing & Managing Hep C providing guidance to Primary Care Providers in hepatitis C screening, management and treatment.
- Sign On | Urge Congress to Appropriate Opioid Funding for Hep C/ HIV February 14, 2018
- Training Manual for Treatment Activists | Hep C & HIV Coinfection February 2, 2018
- Letter to Administration: “America Falls Behind in Hepatitis Elimination Efforts” January 9, 2018
- NY City Council Discretionary Funding Application (Due 2/20/18) December 22, 2017